Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.570
-0.250 (-6.54%)
At close: Jun 27, 2025, 4:00 PM
3.650
+0.080 (2.24%)
After-hours: Jun 27, 2025, 7:04 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $202.66 million as of June 27, 2025. Its market cap has decreased by -5.60% in one year.
Market Cap
202.66M
Enterprise Value
-24.87M
1-Year Change
-5.60%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $202.66M, a decrease of -90.81%. That is a compound annual growth rate of -42.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 216.86M | -37.93% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.32B |
| Johnson & Johnson | 367.29B |
| AbbVie | 329.43B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.61B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.36B |
| AstraZeneca | 215.99B |